nach oben

Erschienen in:

01.06.2019 | Clinical study

Live attenuated vaccines safe in paediatric rheumatic diseases?

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Use of live attenuated vaccines in paediatric patients with rheumatic diseases who are receiving immunosuppressants "is probably safe", say a group of multinational researchers. …

including Israel, Hungary, Australia, Brazil, Greece, Turkey, Italy, Portugal, Netherlands and Slovenia.

Uziel Y, et al. Live Attenuated Vaccines in Pediatric Rheumatic Diseases Are Safe: Multicenter, Retrospective Data Collection. 20th Annual Congress of the European League Against Rheumatism : abstr. OP0205, 12 Jun 2019. Available from: URL: http://scientific.sparx-ip.net/archiveeular/index.cfm?view=2&c=a&item=2019OP0205

Titel: Live attenuated vaccines safe in paediatric rheumatic diseases?
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63899-8

Multiple drugs

Case report

Cancer risk evaluated in PsA patients treated with TNFi

Clinical study

Antivirals

Case report

Ipratropium bromide

Case report

Bcr-abl-tyrosine-kinase inhibitors

Case report

Warfarin

Case report

Springer Medizin

Live attenuated vaccines safe in paediatric rheumatic diseases?

Excerpt

Weitere Artikel der Ausgabe 1/2019

Multiple drugs

Cancer risk evaluated in PsA patients treated with TNFi

Antivirals

Ipratropium bromide

Bcr-abl-tyrosine-kinase inhibitors

Warfarin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Multiple drugs

Cancer risk evaluated in PsA patients treated with TNFi

Antivirals

Ipratropium bromide

Bcr-abl-tyrosine-kinase inhibitors

Warfarin